Patent Yard Sign in
Expired Canadian patentCanada

Pd-l2 molecules: novel pd-1 ligands and uses therefor

CA 2414331 C · Owner: Freeman, Gordon · Inventors: Freeman, Gordon; Chernova, Irene; Malenkovich, Nelly

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides isolated nucleic acids molecules designated PD-L2 , nucleic acid molecules which encode novel B7-related molecules which are ligands for PD-1. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PD-L2 nucleic acid molecules, host cells into which the expression vectors have been introduced and nonhuman transgenic animals in which a PD-L2 gene has been introduced or disrupted. The invention further provides isolated PD-L2 polypeptides fusion , proteins, antigenic peptides and anti-PD-L2 antibodies. The invention still further provides methods for promoting or inhibiting the interaction between PD-L2 and PD-1. …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 28, 2001 and granted November 29, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 28, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 28, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 28, 2001
GrantedNovember 29, 2011
Term endedJune 28, 2021
Patent numberCA 2414331 C
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedJune 28, 2001Patent grantedNov 29, 2011Term endedJune 28, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.